AT360643B - Verfahren zur herstellung einer gamma- globulinfraktion - Google Patents

Verfahren zur herstellung einer gamma- globulinfraktion

Info

Publication number
AT360643B
AT360643B AT958876A AT958876A AT360643B AT 360643 B AT360643 B AT 360643B AT 958876 A AT958876 A AT 958876A AT 958876 A AT958876 A AT 958876A AT 360643 B AT360643 B AT 360643B
Authority
AT
Austria
Prior art keywords
faction
producing
gamma globulin
globulin
gamma
Prior art date
Application number
AT958876A
Other languages
English (en)
Other versions
ATA958876A (de
Inventor
Christian Trepo
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of ATA958876A publication Critical patent/ATA958876A/de
Application granted granted Critical
Publication of AT360643B publication Critical patent/AT360643B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT958876A 1975-12-23 1976-12-23 Verfahren zur herstellung einer gamma- globulinfraktion AT360643B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7539493A FR2336141A1 (fr) 1975-12-23 1975-12-23 Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b

Publications (2)

Publication Number Publication Date
ATA958876A ATA958876A (de) 1980-06-15
AT360643B true AT360643B (de) 1981-01-26

Family

ID=9164075

Family Applications (1)

Application Number Title Priority Date Filing Date
AT958876A AT360643B (de) 1975-12-23 1976-12-23 Verfahren zur herstellung einer gamma- globulinfraktion

Country Status (9)

Country Link
US (1) US4087519A (de)
JP (1) JPS6053009B2 (de)
AT (1) AT360643B (de)
BE (1) BE849615A (de)
CA (1) CA1090701A (de)
DE (1) DE2658170C2 (de)
FR (1) FR2336141A1 (de)
GB (1) GB1569000A (de)
NL (1) NL7614367A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
US5274081A (en) * 1989-09-20 1993-12-28 Immuno A.G. Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5576175A (en) * 1989-09-20 1996-11-19 Immuno Aktiengesellschaft Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
EP0447984A1 (de) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155218A1 (de) * 1970-11-09 1972-09-21 Tokyo Standard Serums, Ltd , Tokio Anti Austrahenantigen Antiserum und Vei fahren zu seiner Herstellung
JPS4948730A (de) * 1972-09-08 1974-05-11

Also Published As

Publication number Publication date
BE849615A (fr) 1977-06-20
CA1090701A (fr) 1980-12-02
US4087519A (en) 1978-05-02
JPS5290620A (en) 1977-07-30
FR2336141B1 (de) 1978-11-03
GB1569000A (en) 1980-06-11
ATA958876A (de) 1980-06-15
DE2658170A1 (de) 1977-07-07
NL7614367A (nl) 1977-06-27
FR2336141A1 (fr) 1977-07-22
JPS6053009B2 (ja) 1985-11-22
DE2658170C2 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
AT344733B (de) Verfahren zur herstellung von schwefelhaltigen organosiliciumverbindungen
DD132091A5 (de) Verfahren zur herstellung einer halbleiteranordnung
AT367070B (de) Verfahren zur herstellung von neunen 2alpha-cyano-3-oxo-steroiden
AT360643B (de) Verfahren zur herstellung einer gamma- globulinfraktion
AT363177B (de) Verfahren zur herstellung einer stabilen thymosinfraktion 5
AT356644B (de) Verfahren zur herstellung von cyclobutanonen
AT346843B (de) Verfahren zur herstellung neuer heteroaryl- verbindungen
AT343286B (de) Verfahren zur herstellung einer topischen zubereitung
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
AT348499B (de) Verfahren zur herstellung von aethylchlorthioformiat
ATA425375A (de) Verfahren zur herstellung von prostaglandinartigen (d1)-verbindungen
AT356129B (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
AT368390B (de) Verfahren zur herstellung einer heterovakzine
DD130786A5 (de) Verfahren zur herstellung von substituierten 2-nitro-3-phenylbenzofuranverbindungen
AT354648B (de) Verfahren zur herstellung einer polyenver- bindung
AT350582B (de) Verfahren zur herstellung von n-mehtyl-harn- stoffen
AT376633B (de) Verfahren zur herstellung von phosphornitriden
ATA274876A (de) Verfahren zur herstellung einer sondennahrung
DD127971A5 (de) Verfahren zur herstellung anionischer monoazoverbindungen
DD130659A5 (de) Verfahren zur herstellung von oxothiaverbindungen
PT64875A (de) Verfahren zur herstellung von n-alenyl-2-aminomethyl-pyrrolidinen
AT362495B (de) Verfahren zur herstellung einer virusvaccine
ATA877276A (de) Verfahren zur herstellung von pyrogallolverbindungen
AT342200B (de) Verfahren zur herstellung von cephalosporinen
DD130910A1 (de) Verfahren zur herstellung einer suessware

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee